financetom
Business
financetom
/
Business
/
Nike's Product Launches Could Drive Sales Turnaround, BofA Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nike's Product Launches Could Drive Sales Turnaround, BofA Says
Jun 21, 2024 8:53 AM

11:35 AM EDT, 06/21/2024 (MT Newswires) -- Nike's ( NKE ) commitment to "faster and more meaningful" product launches could drive sales turnaround in the second half of fiscal 2025, BofA Securities said in a note to clients.

"We have seen green shoots on the innovation front as three of its major retailers...are energized by its new products," BofA said, pointing to Dick's Sporting Goods (DKS), JD Sports and Foot Locker ( FL ) .

The report said consensus estimates are bottoming while the stock is trading at a 10-year trough-relative P/E. BofA kept its buy rating on Nike ( NKE ) with a price objective of $113.

BofA also said that indicators have inflected to upcycle after all six of its Athletic Supply Chain Indicators, including global athletic footwear growth and athletic apparel growth, showed flat or sequential improvement for the 2nd consecutive quarter.

The improvement was driven by suppliers' revenue growth and textile exports of major sourcing countries, the report said.

BofA also kept its buy rating for Adidas, saying that it is in the early stages of multi-year turnaround.

Price: 96.37, Change: +0.80, Percent Change: +0.84

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioNTech Projects 2025 Sales Weakness, Plans R&D Ramp up
BioNTech Projects 2025 Sales Weakness, Plans R&D Ramp up
Mar 10, 2025
11:44 AM EDT, 03/10/2025 (MT Newswires) -- BioNTech (BNTX) reported a decline in fourth-quarter revenue and projected full-year sales to fall again in 2025, while the German drugmaker announced plans to ramp up research and development efforts for future oncology product launches. Revenue declined to 1.19 billion euros ($1.29 billion) for the three months ended Dec. 31 from 1.48 billion...
FactSet Research's Annual Subscription Value Poised to Top Q2 Consensus, RBC Says
FactSet Research's Annual Subscription Value Poised to Top Q2 Consensus, RBC Says
Mar 10, 2025
11:44 AM EDT, 03/10/2025 (MT Newswires) -- FactSet Research Systems' ( FDS ) annual subscription value is poised to top the market consensus in fiscal Q2 following the acquisition of LiquidityBook, RBC Capital Markets said Monday in a report. RBC projects Q2 ASV of $2.32 billion versus the consensus of $2.30 billion with an estimated $18 million from the LiquidityBook...
SenesTech's Financing Move: $1.1 Million From Warrant Exercise, New Deals Loom
SenesTech's Financing Move: $1.1 Million From Warrant Exercise, New Deals Loom
Mar 10, 2025
SenesTech, Inc. ( SNES ) shares are trading lower on Monday. The company inked deals to immediately exercise outstanding warrants for a total of 374,718 shares of common stock, originally issued on August 23, 2024, with a reduced exercise price of $2.90 per share, down from $4.35. Additionally, the company will issue new short-term warrants. The exercise of existing warrants...
Market Chatter: Allstate's National General Faces Lawsuit Over Failure to Report Data Breach
Market Chatter: Allstate's National General Faces Lawsuit Over Failure to Report Data Breach
Mar 10, 2025
11:42 AM EDT, 03/10/2025 (MT Newswires) -- Allstate's ( ALL ) National General unit is being sued by New York state for failing to report a data breach that exposed license numbers and for lacking adequate security measures to protect drivers' private information, Reuters reported Monday. The lawsuit was filed in a Manhattan state court by New York Attorney General...
Copyright 2023-2026 - www.financetom.com All Rights Reserved